SCHEMBL4275166

SCHEMBL4275166

Cn1nc(-c2cc(Br)c(O)c(Br)c2)c2c(N)ncnc21

nearest known ligand 0.71

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PIK3CD O00329 17/20 0.71
PIK3CA P42336 17/20 0.71
PIK3CB P42338 17/20 0.71
PIK3CG P48736 17/20 0.71
PRKDC P78527 17/20 0.71
ABL1 P00519 14/20 0.71
EGFR P00533 14/20 0.71
HCK P08631 14/20 0.71
SRC P12931 14/20 0.71
MTOR P42345 14/20 0.71
EPHB4 P54760 14/20 0.71
KDR P35968 13/20 0.71
PI4KB Q9UBF8 5/20 0.62
NUDT14 O95848 1/20 0.52
NUDT5 Q9UKK9 1/20 0.52
BACE1 P56817 1/20 0.51
AURKA O14965 1/20 0.47
IKBKE Q14164 1/20 0.47
AURKB Q96GD4 1/20 0.47
RET P07949 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4266507 0.91 PIK3CD (0.64) PIK3CDPIK3CAPIK3CBPIK3CGPRKDC
SCHEMBL129595 0.84 PIK3CD (0.62) PIK3CDPIK3CAPIK3CBPIK3CGPRKDC
SCHEMBL23917421 0.83 PIK3CD (1.00) PIK3CDPIK3CAPIK3CBPIK3CGPRKDC
SCHEMBL23917265 0.81 PIK3CD (0.62) PIK3CDPIK3CAPIK3CBPIK3CGPRKDC
SCHEMBL129487 0.79 PIK3CD (0.72) PIK3CDPIK3CAPIK3CBPIK3CGPRKDC
SCHEMBL11807 0.79 PIK3CD (0.60) PIK3CDPIK3CAPIK3CBPIK3CGPRKDC
SCHEMBL16886112 0.79 PIK3CD (0.68) PIK3CDPIK3CAPIK3CBPIK3CGPRKDC
SCHEMBL130419 0.79 PIK3CD (0.70) PIK3CDPIK3CAPIK3CBPIK3CGPRKDC
SCHEMBL130637 0.78 PIK3CD (0.81) PIK3CDPIK3CAPIK3CBPIK3CGPRKDC
SCHEMBL23917454 0.78 PIK3CD (0.65) PIK3CDPIK3CAPIK3CBPIK3CGPRKDC

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090131457-A1 Pyrazolo [3,4-D] Pyrimidine Derivatives Useful to Treat Respiratory Disorders NOVARTIS AG (CH) 2009-05-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090131457-A1 Pyrazolo [3,4-D] Pyrimidine Derivatives Useful to Treat Respiratory Disorders PIK3CA, JAK3, PDK1 PIK3CD 7/4885PIK3CA 1/4885PIK3CB 12/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.